ATE205736T1 - Stabilisierte zwischenschicht für iontophorese - Google Patents

Stabilisierte zwischenschicht für iontophorese

Info

Publication number
ATE205736T1
ATE205736T1 AT96104195T AT96104195T ATE205736T1 AT E205736 T1 ATE205736 T1 AT E205736T1 AT 96104195 T AT96104195 T AT 96104195T AT 96104195 T AT96104195 T AT 96104195T AT E205736 T1 ATE205736 T1 AT E205736T1
Authority
AT
Austria
Prior art keywords
drug
water
soluble protein
matrix
iontophoresis
Prior art date
Application number
AT96104195T
Other languages
English (en)
Inventor
Katsumi Iga
Masafumi Misaki
Keiichiro Okabe
Emi Kyo
Original Assignee
Hisamitsu Pharmaceutical Co
Advance Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co, Advance Co Ltd filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE205736T1 publication Critical patent/ATE205736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/249921—Web or sheet containing structurally defined element or component
    • Y10T428/249953—Composite having voids in a component [e.g., porous, cellular, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
AT96104195T 1995-03-17 1996-03-15 Stabilisierte zwischenschicht für iontophorese ATE205736T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8629195 1995-03-17

Publications (1)

Publication Number Publication Date
ATE205736T1 true ATE205736T1 (de) 2001-10-15

Family

ID=13882743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96104195T ATE205736T1 (de) 1995-03-17 1996-03-15 Stabilisierte zwischenschicht für iontophorese

Country Status (5)

Country Link
US (1) US5837281A (de)
EP (1) EP0732122B1 (de)
AT (1) ATE205736T1 (de)
CA (1) CA2171909A1 (de)
DE (1) DE69615243T2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
JP4154016B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置およびその組み立て方法
JPH11239621A (ja) * 1998-02-25 1999-09-07 Hisamitsu Pharmaceut Co Inc イオントフォレーシス装置
AU769693B2 (en) * 1999-04-12 2004-01-29 Hisamitsu Pharmaceutical Co. Inc. Iontophoresis device
US6926898B2 (en) * 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
KR100452752B1 (ko) * 2000-04-18 2004-10-12 주식회사 펩트론 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제
US6629968B1 (en) * 2000-06-30 2003-10-07 Vyteris, Inc. Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
US20040057983A1 (en) * 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
ATE457822T1 (de) 2003-06-02 2010-03-15 Ge Osmonics Inc Materialien zum verarbeiten nicht-wässeriger mischungen und verfahren zu deren herstellung
IL159273A0 (en) * 2003-12-09 2004-06-01 Transpharma Medical Ltd Transdermal delivery system for sustained release of polypeptides
JP4615929B2 (ja) * 2004-08-11 2011-01-19 久光製薬株式会社 イオントフォレーシス装置
JPWO2006016647A1 (ja) * 2004-08-12 2008-05-01 久光製薬株式会社 マイクロニードル付き経皮薬物投与装置
US7581403B2 (en) * 2005-04-15 2009-09-01 Deeks Daniel H Energy storage arrangement
EP1888001B1 (de) * 2005-06-10 2014-08-06 Syneron Medical Ltd. Patch zur transdermalen wirkstofffreisetzung
JP2009509659A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面への活性物質の送達のイオントフォレーシス装置及び方法
JP2009509657A (ja) 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面への活性物質の送達のイオントフォレーシス装置及び方法
WO2007079193A2 (en) 2005-12-30 2007-07-12 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
EP1996716B1 (de) 2006-03-20 2011-05-11 The Regents of the University of California Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting
US20080058701A1 (en) * 2006-07-05 2008-03-06 Transcutaneous Technologies Inc. Delivery device having self-assembling dendritic polymers and method of use thereof
US20120065576A1 (en) * 2007-08-14 2012-03-15 Stryker Corporation Drug delivery system
US8048044B2 (en) * 2007-08-14 2011-11-01 Stryker Corporation Drug delivery system
WO2009032949A2 (en) * 2007-09-04 2009-03-12 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
CA2704164A1 (en) * 2007-10-29 2009-05-07 Transpharma Medical Ltd. Vertical patch drying
US8602961B2 (en) 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
US20110092881A1 (en) * 2009-05-08 2011-04-21 Isis Biopolymer Inc. Iontophoretic device with contact sensor
CN102421480A (zh) * 2009-05-08 2012-04-18 伊思伊思生物高分子公司 具有改善的反电极的离子电渗设备
JP2017503604A (ja) * 2014-01-22 2017-02-02 マーシオ マーク アブリュー Ａｂｒｅｕ脳熱トンネルでの治療を提供するように構成されたデバイス

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
FR2238700B1 (de) 1973-07-24 1977-10-14 Takeda Chemical Industries Ltd
JPS5726506B2 (de) 1974-03-08 1982-06-04
AT347054B (de) 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
JPS5257177A (en) 1975-10-29 1977-05-11 Parke Davis & Co Production of novel nonapeptide
US4093574A (en) 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4087390A (en) 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
JPS5944308B2 (ja) 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
US4124577A (en) 1977-06-13 1978-11-07 Warner-Lambert Nonapeptides and methods for their production
US4253998A (en) 1979-03-09 1981-03-03 American Home Products Corporation Peptides related to somatostatin
JPS54148722A (en) 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
US4317815A (en) 1979-06-13 1982-03-02 Coy David Howard LH-RH Antagonists
US4253997A (en) 1979-12-17 1981-03-03 American Home Products Corporation Anti-ovulatory decapeptides
JPS5692846A (en) 1979-12-27 1981-07-27 Takeda Chem Ind Ltd Tetrapeptide derivative and its preparation
US4424210A (en) 1980-04-04 1984-01-03 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4328319A (en) * 1980-10-27 1982-05-04 Restech Research Limited Partnership Process for preparing propellant compositions forming foamed structures containing open and/or closed cells
US4738849A (en) * 1984-06-28 1988-04-19 Interface Biomedical Laboratories Corp. Composite medical articles for application to wounds and method for producing same
US5407685A (en) * 1986-02-06 1995-04-18 Steris Corporation Controlled oxygen/anti-microbial release films
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US4876332A (en) * 1987-10-08 1989-10-24 Regents Of The Univeristy Of Minnesota Polypeptides with type IV collagen activity
US4897811A (en) 1988-01-19 1990-01-30 Nestor, Inc. N-dimensional coulomb neural network which provides for cumulative learning of internal representations
ES2053890T3 (es) 1988-09-01 1994-08-01 Takeda Chemical Industries Ltd Agente inhibidor de la angiogenesis.
DE68927904T2 (de) 1988-09-01 1997-09-04 Takeda Chemical Industries Ltd Fumagillol-Derivate
ATE97410T1 (de) 1989-03-06 1993-12-15 Takeda Chemical Industries Ltd 6-amino-6-desoxyfumagillole, ihre herstellung und ihre verwendung.
JP2719671B2 (ja) * 1989-07-11 1998-02-25 日本ゼオン株式会社 創傷被覆材
EP0415294A3 (en) 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
US5167616A (en) * 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
US5344702A (en) * 1990-09-14 1994-09-06 Hoechst Celanese Corp. Coated fibers
USH1160H (en) * 1990-11-26 1993-04-06 Iontophoretic delivery of peptides
US5152996A (en) * 1990-12-10 1992-10-06 Eastman Kodak Company Nonwoven wipes impregnated with an aqueous solution of a zinc acetate peroxide and a surfactant
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
JPH0616535A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼ用インターフェイス
GB2280850B (en) * 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
DE69429603T2 (de) * 1993-09-22 2002-08-14 Hisamitsu Pharmaceutical Co., Inc. Iontophoresematrix

Also Published As

Publication number Publication date
EP0732122B1 (de) 2001-09-19
DE69615243D1 (de) 2001-10-25
US5837281A (en) 1998-11-17
EP0732122A1 (de) 1996-09-18
DE69615243T2 (de) 2002-06-27
CA2171909A1 (en) 1996-09-18

Similar Documents

Publication Publication Date Title
ATE205736T1 (de) Stabilisierte zwischenschicht für iontophorese
ATE248004T1 (de) Schnittstelle für iontophorese
ATE133078T1 (de) Einrichtung zur transdermalen wirkstoffabgabe
CY1114000T1 (el) Σταθεροποιημενα διαλυματα τεριπαρατιδης
MX9502034A (es) Formulacion estable, liofilizada, que comprende una proteina y equipo de dosificacion.
ATE255450T1 (de) Matrix für iontophorese
FI973452A0 (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
HU900108D0 (en) Composition of controlled active ingredient delivery, operating by hydrogel
ATE229327T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen
BG42182A3 (en) Vaginal ring
NO994087L (no) Vedvarende analgesi oppnaadd med buprenorfin
GR3015363T3 (en) Use of a heavily soluble salt of a heteropolyacid for the determination of an analyte a corresponding assay and means useful therefor.
IT8567165A1 (it) Composizioni a base di liposomi, particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi, e relativo procedimento d'impiego.
ATE261742T1 (de) Pulmonale verabreichung von medikamenten in aerosolform
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
DE69802543D1 (de) Verbesserte multipartikel-tablette mit schnellauflösbarkeit
DK156289D0 (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
GR3003289T3 (en) Drug-containing plaster of the sustained-release type
DE3571552D1 (en) Preparation containing stabilized polypeptide having gamma-interferon activity
ATE98876T1 (de) Pharmazeutische praeparate.
EP1952819A3 (de) Verfahren zur Prävention von Gastritis mit Amylin und Amylin-Agonisten
TR199903069T2 (xx) Etkin madde olarak bir ace inhibit�r� i�eren kontroll�-sal�m farmas�tik preparat�.
CA2242224A1 (fr) Microgranules a liberation prolongee contenant du diltiazem comme principe actif
Bozou et al. Phorbol ester induces loss of VIP stimulation of adenylate cyclase and VIP‐binding sites in HT29 cells
Sinay et al. Intranasal insulin administration in insulin dependent diabetes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties